KMT2A and microcephaly: Clinical genetics studies identified MLL1/KMT2A pathogenic variants in patients diagnosed with either Kabuki syndrome or Rubinstein–Taiby syndrome which are characterized by ID, postnatal growth defects and microcephaly (Sobreira et al., 2017; Castiglioni et al., 2022).